Related Experiment Video
Updated: Mar 26, 2026

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
Assessment of the New 2012 EULAR/ACR Clinical Classification Criteria for Polymyalgia Rheumatica: A Prospective
Gulsen Ozen1, Nevsun Inanc1, Ali Ugur Unal1
1From the Department of Rheumatology, and Department of Physical Therapy and Rehabilitation, Faculty of Medicine, Marmara University; Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Goztepe Medeniyet University; Department of Rheumatology, Fatih Sultan Mehmet Education and Research Hospital; Department of Rheumatology, Faculty of Medicine, Bilim University, Istanbul; Department of Rheumatology, Faculty of Medicine, Gaziantep University, Gaziantep; Department of Rheumatology, Faculty of Medicine, Pamukkale University, Denizli; Department of Rheumatology, Sakarya Education and Research Hospital, Sakarya; Department of Rheumatology, Suleyman Demirel University, Isparta; Department of Rheumatology, Faculty of Medicine, Cumhuriyet University, Sivas; Department of Rheumatology, Faculty of Medicine, Erciyes University, Kayseri; Department of Rheumatology, Faculty of Medicine, Trakya University, Edirne; Department of Rheumatology, Selcuklu Faculty of Medicine, Selcuk University, Konya; Department of Rheumatology, Faculty of Medicine, Ege University, Izmir; Department of Rheumatology, Faculty of Medicine, Ondokuz Mayis University, Samsun; Department of Rheumatology, Faculty of Medicine, Sutcu Imam University, Kahramanmaras; Department of Rheumatology, Yunus Emre Government Hospital, Eskisehir, Turkey; Department of Rheumatology, School of Medicine, University of Ottawa, Ottawa, Ontario, Canada.G. Ozen, MD, Department of Rheumatology, Faculty of Medicine, Marmara University; N. Inanc, MD, Professor, Department of Rheumatology, Faculty of Medicine, Marmara University; A.U. Unal, MD, Department of Rheumatology, Faculty of Medicine, Marmara University; S. Bas, MD, Department of Rheumatology, Faculty of Medicine, Marmara University; G. Kimyon, MD, Department of Rheumatology, Faculty of Medicine, Gaziantep University; B. Kisacik, MD, Professor, Department of Rheumatology, Faculty of Medicine, Gaziantep University; A.M. Onat, MD, Professor, Department of Rhe
Objective:
To assess the performance of the new 2012 provisional European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) polymyalgia rheumatica (PMR) clinical classification criteria in discriminating PMR from other mimicking conditions compared with the previous 5 diagnostic criteria in a multicenter prospective study.
Methods:
Patients older than 50 years, presenting with new-onset bilateral shoulder pain with elevated acute-phase reactants (APR), were assessed for the fulfillment of the new and old classification/diagnostic criteria sets for PMR. At the end of the 1-year followup, 133 patients were diagnosed with PMR (expert opinion) and 142 with non-PMR conditions [69 rheumatoid arthritis (RA)]. Discriminating capacity, sensitivity, and specificity of the criteria sets were estimated.
Results:
Discriminating capacity of the new clinical criteria for PMR from non-PMR conditions and RA as estimated by area under the curve (AUC) were good with AUC of 0.736 and 0.781, respectively. The new criteria had a sensitivity of 89.5% and a specificity of 57.7% when tested against all non-PMR cases. When tested against all RA, seropositive RA, seronegative RA, and non-RA control patients, specificity changed to 66.7%, 100%, 20.7%, and 49.3%, respectively. Except for the Bird criteria, the 4 previous criteria had lower sensitivity and higher specificity (ranging from 83%-93%) compared with the new clinical criteria in discriminating PMR from all other controls.
Conclusion:
The new 2012 EULAR/ACR clinical classification criteria for PMR is highly sensitive; however, its ability to discriminate PMR from other inflammatory/noninflammatory shoulder conditions, especially from seronegative RA, is not adequate. Imaging and other modifications such as cutoff values for APR might increase the specificity of the criteria.
Insights
The new 2012 European League Against Rheumatism/American College of Rheumatology criteria for polymyalgia rheumatica (PMR) show high sensitivity but need improvement in specificity, particularly for distinguishing PMR from seronegative rheumatoid arthritis (RA). Further modifications may enhance diagnostic accuracy.
Area of Science:
- Rheumatology
- Clinical Classification
- Diagnostic Criteria
Background:
- Polymyalgia rheumatica (PMR) diagnosis can be challenging due to overlapping symptoms with other conditions.
- Existing diagnostic criteria require evaluation against newer classification systems.
Purpose of the Study:
- To compare the performance of the 2012 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) PMR classification criteria against previous criteria.
- To assess the ability of the new criteria to differentiate PMR from mimicking conditions in a multicenter prospective study.
Main Methods:
- A prospective, multicenter study evaluated patients over 50 with new-onset bilateral shoulder pain and elevated acute-phase reactants (APR).
- Patients were assessed using both the 2012 EULAR/ACR criteria and previous diagnostic criteria.
- Discriminating capacity, sensitivity, and specificity were calculated after a 1-year follow-up, with 133 diagnosed with PMR and 142 with non-PMR conditions (including RA).
Main Results:
- The 2012 EULAR/ACR criteria demonstrated good discriminating capacity (AUC 0.736 for non-PMR, 0.781 for RA) and high sensitivity (89.5%).
- Specificity was 57.7% against all non-PMR cases and varied significantly against specific conditions (e.g., 20.7% for seronegative RA).
- Previous criteria, except Bird criteria, generally showed lower sensitivity but higher specificity compared to the new criteria.
Conclusions:
- The 2012 EULAR/ACR criteria are highly sensitive for diagnosing PMR.
- However, their specificity is insufficient for differentiating PMR from other inflammatory and noninflammatory shoulder conditions, especially seronegative RA.
- Enhancements like incorporating imaging or adjusting APR cutoff values may improve the specificity of these criteria.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy IV: Restrictive Cardiomyopathy
Rheumatic Heart Disease III: Medical Management
Pericarditis II: Clinical Features and Diagnostic Tests
Myocarditis II: Clinical Features and Diagnostic Tests
Rheumatic Heart Disease IV: Nursing Management

